When issues arise, many people think filing a lawsuit is the answer. That will initiate the litigation process, which will most likely involve an exchange of information and documents, the process of taking depositions, and probably some motion practice along the way. While in some cases it certainly is, we typically counsel new clients (and
Services agreements are a problem in the Oregon cannabis industry. These agreements have been around since at least 2016, when our office and at least one other law firm developed early templates in consultation with the Oregon Liquor and Cannabis Commission (“OLCC”). That form was called a “management agreement” and you will see them referred
Cannabis purchase order financing is gaining speed in the industry. Because of robust state regulation, high operational costs, high taxes, and the federal illegality of marijuana, a lot of cannabis businesses struggle financially in their day to day business operations. Approaches to this problem takes various shapes and forms across the industry. There are threats
This post looks at the two most common product development choices, with a focus on how they impact the transition to mass production. At this stage, the foreign company has typically approved a final prototype — or it is close to that stage — and it it looking at going into mass production with their Chinese manufacturer.
Time for another Oregon psilocybin licensing discussion update. We have now crossed the halfway point of the Oregon Health Authority (OHA) two-year development phase to create regulations based on Ballot Measure 109. As a reminder, there are five subcommittees covering different aspects of the emerging psilocybin industry. They include: research, health equity, manufacturing, training, and
The year 2021 began with high hopes for international trade as many thought the incoming Biden Administration would undo many of the unprecedented trade actions taken by the Trump Administration and reset U.S. trade policy. However, at the end of 2021, most of the Trump tariffs remain in effect and the Biden Administration has largely pushed trade issues to the back burner. Here, we take a look at some of developments on the Trump tariffs this past year and what to expect for those tariffs in 2022.
Contract manufacturing is fundamentally the purchase of a product. For any product purchase, the key terms are price, quantity and delivery date. And yet many buyers treat these key term as secondary issues. As buyers focus on exciting issues like product design and “getting to market”, buyers frequently fall into a trap. They assume that price, quantity and delivery terms will never be an issue. When these issues arise, as they virtually always do, the product buyer is in a situation where it has little to no room to negotiate. The overseas factory is now in control, and then it springs the price trap.
Time for an Oregon psilocybin licensing discussion update. Ballot Measure 109 gave the Oregon Health Authority (“OHA”) two years to create regulations for the manufacturing, testing, sale, and supervised administration of psilocybin. This two-year development phase started on January 1, 2021, and on March 18 Governor Kate Brown appointed members to the Oregon Psilocybin Advisory
Psychedelics developments in 2021 covered everything from legalization and decriminalization to pharmaceutical advances and public company milestones.
DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back
